Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells.

Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN.

J Biol Chem. 2001 Aug 10;276(32):29681-7. Epub 2001 Jun 7.

2.

Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.

Gupta RA, Sarraf P, Brockman JA, Shappell SB, Raftery LA, Willson TM, DuBois RN.

J Biol Chem. 2003 Feb 28;278(9):7431-8. Epub 2002 Dec 4.

3.

Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms.

Gupta RA, Sarraf P, Mueller E, Brockman JA, Prusakiewicz JJ, Eng C, Willson TM, DuBois RN.

J Biol Chem. 2003 Jun 20;278(25):22669-77. Epub 2003 Feb 18.

4.

Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.

Begum NM, Nakashiro K, Kawamata H, Uchida D, Shintani S, Ikawa Y, Sato M, Hamakawa H.

Int J Oncol. 2002 Mar;20(3):599-605.

PMID:
11836575
5.
6.

Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.

Xu Y, Iyengar S, Roberts RL, Shappell SB, Peehl DM.

J Cell Physiol. 2003 Jul;196(1):131-43.

PMID:
12767049
7.

Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.

Kast-Woelbern HR, Dana SL, Cesario RM, Sun L, de Grandpre LY, Brooks ME, Osburn DL, Reifel-Miller A, Klausing K, Leibowitz MD.

J Biol Chem. 2004 Jun 4;279(23):23908-15. Epub 2004 Apr 8.

8.

A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus.

Berger J, Patel HV, Woods J, Hayes NS, Parent SA, Clemas J, Leibowitz MD, Elbrecht A, Rachubinski RA, Capone JP, Moller DE.

Mol Cell Endocrinol. 2000 Apr 25;162(1-2):57-67.

PMID:
10854698
9.

T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.

Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, Amaral K, Nakamura M, Miao S, Cao P, Learned RM, Chen JL, Li Y.

J Biol Chem. 2002 May 31;277(22):19649-57. Epub 2002 Mar 4.

11.

Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.

Li X, Hansen PA, Xi L, Chandraratna RA, Burant CF.

J Biol Chem. 2005 Nov 18;280(46):38317-27. Epub 2005 Sep 22.

12.

Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.

Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM, Law RE.

Circ Res. 2003 Aug 22;93(4):e38-47. Epub 2003 Jul 24.

13.
14.
15.

Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.

Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE.

J Biol Chem. 2004 Feb 20;279(8):6883-92. Epub 2003 Dec 8.

17.

Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.

Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL.

Mol Genet Metab. 2001 Nov;74(3):362-9.

PMID:
11708867
18.
19.

Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways.

Berge K, Tronstad KJ, Flindt EN, Rasmussen TH, Madsen L, Kristiansen K, Berge RK.

Carcinogenesis. 2001 Nov;22(11):1747-55.

PMID:
11698335
20.

15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.

Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN.

Cancer Res. 2001 Jan 15;61(2):497-503.

Supplemental Content

Support Center